These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 25485919)

  • 1. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of Testosterone Therapy.
    Lee OD; Tillman K
    Am J Mens Health; 2016 Jan; 10(1):68-72. PubMed ID: 25398416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Testosterone therapy].
    Diemer T; Hauptmann A; Wagenlehner FM
    Urologe A; 2016 Apr; 55(4):539-48; quiz 549-50. PubMed ID: 27067659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotestosteronaemia in the aging male: should we treat it?
    Christe N; Meier CA
    Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male Sexual Dysfunction and Hypogonadism Guidelines for the Aging Male.
    Ahmed K; Hatzimouratidis K; Muneer A
    Eur Urol Focus; 2017 Oct; 3(4-5):514-516. PubMed ID: 29331623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
    Brunton SA; Sadovsky R
    J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-life onset hypogonadism: a review.
    Bassil N; Morley JE
    Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of hypogonadism in men.
    Bhasin S; Basaria S
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):251-70. PubMed ID: 21397197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement therapy for older men.
    Wald M; Meacham RB; Ross LS; Niederberger CS
    J Androl; 2006; 27(2):126-32. PubMed ID: 16474018
    [No Abstract]   [Full Text] [Related]  

  • 15. Testosterone therapy: treatment of metabolic disturbances in heart failure.
    Naghi JJ; Philip KJ; DiLibero D; Willix R; Schwarz ER
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):14-23. PubMed ID: 21097668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of endocrinologic male sexual dysfunction.
    Nehra A
    Mayo Clin Proc; 2000 Jan; 75 Suppl():S40-5. PubMed ID: 10959215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Andropause (androgen deficiency of the aging male): diagnosis and management.
    Staerman F; Léon P
    Minerva Med; 2012 Oct; 103(5):333-42. PubMed ID: 23042368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Testosterone substitution in patients with hypogonadism].
    Martínez Portillo FJ; Cueva Martínez A; Martin Braun P; Fernández Arancibia MI; Jünemann KP; Alken P
    Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone replacement therapy and cardiovascular events.
    Çatakoğlu AB; Kendirci M
    Turk Kardiyol Dern Ars; 2017 Oct; 45(7):664-672. PubMed ID: 28990951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.